Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes

Decitabine treatment improves immunological recognition that increases expression of cancer-testis antigens (CTAs) against solid tumors. The mechanisms of decitabine enhancement of immunogenicity when used for patients with myelodysplastic syndromes (MDS) remain unclear. In the present study, we fou...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Transl Res
Hlavní autoři: Zhang, Zheng, He, Qi, Tao, Ying, Guo, Juan, Xu, Feng, Wu, Ling-Yun, Zhao, You-Shan, Wu, Dong, Zhou, Li-Yu, Su, Ji-Ying, Song, Lu-Xi, Xiao, Chao, Li, Xiao, Chang, Chun-Kang
Médium: Artigo
Jazyk:Inglês
Vydáno: e-Century Publishing Corporation 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5340681/
https://ncbi.nlm.nih.gov/pubmed/28337274
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky